AVSOLA 100 mg/10mL
infliximab-axxq · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Amgen, Inc
AVSOLA is a injection, powder, lyophilized, for solution containing infliximab-axxq at 100 mg/10mL, taken intravenous. Manufactured by Amgen, Inc.
Key Facts
- Brand Name
- AVSOLA
- Generic Name
- infliximab-axxq
- NDC Code (Product)
55513-670- Manufacturer
- Amgen, Inc
- Strength
- 100 mg/10mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761086
- Drug Class
- Tumor Necrosis Factor Blocker [EPC]
- Marketing Start
- 12/12/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is AVSOLA used for?
AVSOLA contains infliximab-axxq. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is AVSOLA a controlled substance?
AVSOLA is not classified as a controlled substance by the DEA.
What is the generic name for AVSOLA?
The generic name for AVSOLA is infliximab-axxq. There are no other listed brand versions of infliximab-axxq.
What is the NDC code for AVSOLA 100 mg/10mL?
The NDC (National Drug Code) for AVSOLA 100 mg/10mL is 55513-670, listed by Amgen, Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)